Plantopia Secures $9 Million to Scale Animal-Free Dairy Protein Production

The funding round, led by dairy producer Calcalistech and investment firm Siddhi Capital, brings the company’s total capital raised to more than $16 million. This investment marks a significant shift for the firm, which was founded in 2018 by Prof. Alexander Vainstein, Tal Lutzky, and Amir Tiroler, based on research originating from the Hebrew University of Jerusalem’s Faculty of Agriculture.

Molecular Farming vs. Precision Fermentation

Plantopia’s approach to producing dairy proteins relies on molecular farming, a method that uses plants as biological factories rather than the microbial fermentation vats commonly used by other industry players. By engineering plants to express dairy proteins, the company aims to bypass the high capital costs and energy demands associated with industrial-scale fermentation.

According to the company’s leadership, their platform is the first to produce all four major casein subtypes—αs1, αs2, β, and κ—which are essential for the texture and melting properties of cheese. The resulting proteins are described as chemically identical to those found in cow’s milk but are produced without the use of livestock, lactose, or significant agricultural land.

“Plantopia’s technological achievement is the holy grail of dairy proteins – proteins that are identical in composition to those found in cow’s milk. They will help meet the growing demand for dairy proteins while enabling us to produce products that are as good as the original, providing a commercially viable alternative to one of the world’s largest sources of pollution.”

Tal Lutzky, CEO and co-founder of Plantopia

The Discovery of Unexpected Protein Storage

Beyond the startup’s commercial progress, recent scientific research has shed light on how plants can be optimized to produce these complex proteins. In a study published in Frontiers in Plant Science, researchers from the Hebrew University of Jerusalem, including Prof. Oded Shoseyov, discovered that bovine β-casein can accumulate in plant seeds in an unexpected location.

While the team initially targeted the protein to specialized storage vacuoles, electron microscopy revealed that the protein instead formed structures resembling natural casein micelles, clustered around oil bodies within the seed cells.

“We set out to send the protein to one location inside the cell, but instead discovered that the plant had effectively created its own storage solution. Understanding this unexpected behavior gives us valuable insight into how plants handle complex proteins and may help us engineer more efficient systems for producing sustainable dairy proteins in the future.”

Prof. Oded Shoseyov, Hebrew University of Jerusalem

Market Drivers and Protein Demand

The company attributes rising demand for alternative proteins partly to shifting consumer habits and the increased prevalence of GLP-1 weight-loss medications.

Data cited by the company suggests that approximately 12% of the U.S. population uses these weight-management drugs, which often necessitate higher protein intake to mitigate potential muscle loss. Consequently, the firm reports that dairy protein consumption in the United States has increased by 83% over the past two years, accompanied by a 250% rise in prices. These market conditions provide a strong incentive for the development of sustainable, cost-competitive alternatives to traditional dairy production.

Next Steps for Commercial Production

With the new funding secured, the company is focused on the third-quarter launch of its production facility at Kibbutz Sdot Yam. As the facility prepares to begin operations, the broader scientific community continues to explore how these findings might extend beyond dairy.